BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23980047)

  • 21. [The RAS paradox of the EGFR-targeted therapy in colorectal cancer].
    Tímár J; Láng I
    Magy Onkol; 2008 Jun; 52(2):185-91. PubMed ID: 18640895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
    Herz C; Schlürmann F; Batarello D; Fichter CD; Schöpflin A; Münch C; Hauschke D; Werner M; Lassmann S
    Mol Carcinog; 2012 Sep; 51(9):696-710. PubMed ID: 21739483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association between radiosensitivity and TP53 status, G1 arrest or protein levels of p53, myc, ras or raf in human melanoma lines.
    Danielsen T; Smith-Sørensen B; Grønlund HA; Hvidsten M; Børresen-Dale AL; Rofstad EK
    Int J Radiat Biol; 1999 Sep; 75(9):1149-60. PubMed ID: 10528923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
    Spagnoletti G; Li Bergolis V; Piscazzi A; Giannelli F; Condelli V; Sisinni L; Bove G; Storto G; Landriscina M
    Tumour Biol; 2018 Apr; 40(4):1010428318770957. PubMed ID: 29663854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosensitivity, apoptosis and repair of DNA double-strand breaks in radiation-sensitive Chinese hamster ovary cell mutants treated at different dose rates.
    Hu Q; Hill RP
    Radiat Res; 1996 Dec; 146(6):636-45. PubMed ID: 8955713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
    Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
    Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cells.
    Wang XK; Zhou FF; Tao HR; Wang X; Zhang C; Su F; Wang SP; Xu LH; Pan XK; Feng MH; Xie W
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):880-885. PubMed ID: 29270747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long non-coding RNA influences radiosensitivity of colorectal carcinoma cell lines by regulating cyclin D1 expression].
    Yu ZQ; Zhang C; Lao XY; Wang H; Gao XH; Cao GW; Zhou WP; Fu CG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):288-91. PubMed ID: 22454180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Down regulation of multidrug resistance-associated protein 4 expression by RNA interference enhances radiosensitivity of colorectal carcinoma cell lines in vitro].
    Yu ZQ; Zhang C; Cai R; Lao XY; Wang H; Gao XH; Han YF; Zhang XQ; Cao GW; Fu CG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jan; 15(1):67-71. PubMed ID: 22287356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.
    Monstein HJ; Fransén K; Dimberg J; Söderkvist P
    Eur J Clin Invest; 2004 Feb; 34(2):100-6. PubMed ID: 14764072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins.
    Xu X; Wu Y; Yi K; Hu Y; Ding W; Xing C
    Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
    Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
    Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
    Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
    Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
    Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
    Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa).
    Burdak-Rothkamm S; Rübe CE; Nguyen TP; Ludwig D; Feldmann K; Wiegel T; Rübe C
    Strahlenther Onkol; 2005 Mar; 181(3):197-204. PubMed ID: 15756525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.
    Pietrantonio F; Petrelli F; Coinu A; Di Bartolomeo M; Borgonovo K; Maggi C; Cabiddu M; Iacovelli R; Bossi I; Lonati V; Ghilardi M; de Braud F; Barni S
    Eur J Cancer; 2015 Mar; 51(5):587-94. PubMed ID: 25673558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.